Table 1. Patient and graft characteristics.
| Age (years) | 49 (28–66) | |
| Gender (male/female) | 9/1 | |
| MELD-score | 6 (6–13) | |
| Child-Pugh score | 5 (5–7) | |
| Mayo risk score | -0.23 (-1.45–2.09) | |
| Cold ischemic time (hours) | 4.7 (3.5–9.7) | |
| Time from the beginning of surgery until portal vein clamping (minutes) | 174 (135–209) | |
| Anhepatic time (minutes) | 51 (44–80) | |
| Time from portal vein declamping until hepatic artery declamping (minutes) | 31 (21–47) | |
| Perioperative bleeding (mL) | 1600 (900–2600) | |
| Graft steatosis | ||
| Grafts with any steatosis (n) | 6 | |
| Macrovesicular (%) | 0 (0–20) | |
| Microvesicular (%) | 0 (0–95) | |
| Postoperative liver function | ||
| peak ALT (IU/L) | 438 (213–2191) | |
| INR on day 7 | 1.2 (1.0–1.3) | |
| Bilirubin on day 7 (μmol/L) | 17 (7–154) | |
| MEAF-score | 2.84 (1.38–4.81) | |
Data are expressed as medians (range). MELD, Model for End-stage Liver Disease; ALT, alanine aminotransferase; INR, international normalized ratio; MEAF, Model for Early Allograft Function.